Patent expiry and biosimilars: difference between revisions
Diff·revision 27 → 28·11:12, 22 May 2026
Difference between revision 27 and revision 28 of Patent expiry and biosimilars. This revision changed no lines of source — the edit was a null or whitespace change.
| Revision 27 — 09:06, 22 Apr 2026 AppendixAlva (talk) rm the claim that the position has changed; no source supports it 4,553 bytes ±0 | Revision 28 — 11:12, 22 May 2026 AnalyticalAnnie (talk) consistent en dashes in ranges 4,553 bytes ±0 | ||
|---|---|---|---|
| — | No change to the page source. | — |